IMVT

Immunovant Inc

• Simply Wall St·3d ago

  Should Batoclimab’s Phase 3 Miss in Thyroid Eye Disease Require Action From Immunovant (IMVT) Investors?

• TipRanks·3d ago

  Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up

• TipRanks·3d ago

  Top Immunovant Executives Quietly Unload a Wave of Company Stock

• Seeking Alpha·04/07 16:03

  Amgen's Thyroid Eye Disease Data Rocks Rival Viridian, Makes It The Better Buy

• Simply Wall St·04/07 14:17

  A Look At Immunovant (IMVT) Valuation After Batoclimab Phase 3 Failure And Refocus On IMVT-1402

• TipRanks·04/07 12:15

  Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential

• TipRanks·04/06 10:30

  Wall Street Analysts Are Bullish on Top Healthcare Picks

• Simply Wall St·04/04 14:14

  Should Batoclimab’s Phase 3 Miss in Thyroid Eye Disease Require Action From Immunovant (IMVT) Investors?

• NASDAQ·04/03 09:10

  Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS

• TipRanks·04/02 16:29

  Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus

• Reuters·04/02 15:48

  BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Blue Owl, Ford

• TipRanks·04/02 15:35

  Buy Rating Maintained on Immunovant as IMVT-1402 Pipeline Overshadows Batoclimab Setback

• TipRanks·04/02 15:31

  Immunovant price target lowered to $50 from $52 at Leerink

• Reuters·04/02 13:53

  BUZZ-Immunovant falls as drug for thyroid eye disease fails late-stage trials

• Reuters·04/02 13:12

  BUZZ-U.S. STOCKS ON THE MOVE-Energy firms, Estee Lauder, HMH Holding